| Name | Title | Contact Details |
|---|
UCG is the foremost company in the industry, offering a full platform of cannabis manufacturing services guiding clients from the ground up.
NextGen Healthcare is on a relentless quest to improve the lives of those who practice medicine and those they care for. We provide tailored solutions to fit the precise needs of ambulatory practices, as they strive to reach the quadruple aim while navigating the journey of value-based care. The result? Healthier patients and happier providers.
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work. From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.
At DCHS, our mission is simple: to improve health every day. We are seeking providers to join our group who will share in our mission and help to cultivate our vision…to be the healthcare provider of choice for the communities we serve. Be an integral partner with one of the country`s top-ranked, most respected healthcare systems. As a system, DCHS is dedicated to purchasing the most advanced technology, operating state-of-the-art facilities and introducing new and innovative models of care. Vision, passion, perseverance, knowledge, skill, dedication, warmth, caring, technology, and people, have come together like a finely woven tapestry to create a healthcare experience for our patients that we call the Dickinson Difference.
The American Association for Thoracic Surgery is an international organization of over 1,500 of the worlds foremost cardiothoracic surgeons representing 41 countries. The mission of the AATS is to promote scholarship, innovation, and leadership in tho...